STRO
Price
$0.80
Change
-$0.01 (-1.23%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
67.48M
41 days until earnings call
TRDA
Price
$6.99
Change
-$0.07 (-0.99%)
Updated
Jun 26, 04:59 PM (EDT)
Capitalization
266.43M
40 days until earnings call
Interact to see
Advertisement

STRO vs TRDA

Header iconSTRO vs TRDA Comparison
Open Charts STRO vs TRDABanner chart's image
Sutro Biopharma
Price$0.80
Change-$0.01 (-1.23%)
Volume$50.73K
Capitalization67.48M
Entrada Therapeutics
Price$6.99
Change-$0.07 (-0.99%)
Volume$1.84K
Capitalization266.43M
STRO vs TRDA Comparison Chart in %
Loading...
STRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
STRO vs. TRDA commentary
Jun 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is STRO is a Buy and TRDA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 27, 2025
Stock price -- (STRO: $0.80 vs. TRDA: $7.02)
Brand notoriety: STRO and TRDA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: STRO: 78% vs. TRDA: 77%
Market capitalization -- STRO: $67.48M vs. TRDA: $266.43M
STRO [@Biotechnology] is valued at $67.48M. TRDA’s [@Biotechnology] market capitalization is $266.43M. The market cap for tickers in the [@Biotechnology] industry ranges from $301.01B to $0. The average market capitalization across the [@Biotechnology] industry is $2.35B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

STRO’s FA Score shows that 1 FA rating(s) are green whileTRDA’s FA Score has 0 green FA rating(s).

  • STRO’s FA Score: 1 green, 4 red.
  • TRDA’s FA Score: 0 green, 5 red.
According to our system of comparison, both STRO and TRDA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

STRO’s TA Score shows that 3 TA indicator(s) are bullish while TRDA’s TA Score has 4 bullish TA indicator(s).

  • STRO’s TA Score: 3 bullish, 5 bearish.
  • TRDA’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, TRDA is a better buy in the short-term than STRO.

Price Growth

STRO (@Biotechnology) experienced а +0.66% price change this week, while TRDA (@Biotechnology) price change was -0.14% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.59%. For the same industry, the average monthly price growth was +34.25%, and the average quarterly price growth was +14.95%.

Reported Earning Dates

STRO is expected to report earnings on Aug 07, 2025.

TRDA is expected to report earnings on Aug 06, 2025.

Industries' Descriptions

@Biotechnology (+3.59% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TRDA($266M) has a higher market cap than STRO($67.5M). STRO (-56.576) and TRDA (-59.398) have similar YTD gains . TRDA has higher annual earnings (EBITDA): 7.89M vs. STRO (-203.18M). TRDA has more cash in the bank: 383M vs. STRO (249M). STRO has less debt than TRDA: STRO (21.4M) vs TRDA (57M). TRDA has higher revenues than STRO: TRDA (172M) vs STRO (66.4M).
STROTRDASTRO / TRDA
Capitalization67.5M266M25%
EBITDA-203.18M7.89M-2,574%
Gain YTD-56.576-59.39895%
P/E RatioN/A12.10-
Revenue66.4M172M39%
Total Cash249M383M65%
Total Debt21.4M57M38%
FUNDAMENTALS RATINGS
STRO: Fundamental Ratings
STRO
OUTLOOK RATING
1..100
5
VALUATION
overvalued / fair valued / undervalued
1..100
27
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
STROTRDA
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
89%
Bullish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
88%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
86%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
87%
Advances
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 21 days ago
85%
Declines
ODDS (%)
Bearish Trend 14 days ago
87%
Bearish Trend 10 days ago
86%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
77%
Bullish Trend 2 days ago
90%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Interact to see
Advertisement
STRO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRDA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
JPM288.754.69
+1.65%
JPMorgan Chase & Co
RMR16.640.16
+0.97%
RMR Group (The)
ARQT14.400.07
+0.49%
Arcutis Biotherapeutics
KORE2.35-0.01
-0.39%
KORE Group Holdings
FCN160.11-1.56
-0.96%
FTI Consulting

STRO and

Correlation & Price change

A.I.dvisor indicates that over the last year, STRO has been loosely correlated with ALGS. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if STRO jumps, then ALGS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To STRO
1D Price
Change %
STRO100%
-0.78%
ALGS - STRO
44%
Loosely correlated
-6.42%
TCRX - STRO
40%
Loosely correlated
-11.90%
TRDA - STRO
40%
Loosely correlated
-0.57%
ATXS - STRO
40%
Loosely correlated
-3.72%
FATE - STRO
38%
Loosely correlated
-5.17%
More

TRDA and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRDA has been loosely correlated with CRNX. These tickers have moved in lockstep 57% of the time. This A.I.-generated data suggests there is some statistical probability that if TRDA jumps, then CRNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRDA
1D Price
Change %
TRDA100%
-0.57%
CRNX - TRDA
57%
Loosely correlated
-1.38%
ARCT - TRDA
52%
Loosely correlated
+3.30%
BEAM - TRDA
52%
Loosely correlated
+2.27%
VYGR - TRDA
51%
Loosely correlated
+1.02%
ATXS - TRDA
51%
Loosely correlated
-3.72%
More